Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer.

Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer.

http://www.wikidata.org/entity/Q39929797

about

Patient-derived tumour xenografts as models for oncology drug development The Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC models.Approaches for defining the Hsp90-dependent proteome.HSP90 inhibition enhances antimitotic drug-induced mitotic arrest and cell death in preclinical models of non-small cell lung cancer High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer.Novel role of VMP1 as modifier of the pancreatic tumor cell response to chemotherapeutic drugs.Proteomics in pancreatic cancer research.Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells.A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws.Synergetic cytotoxic activity toward breast cancer cells enhanced by the combination of Antp-TPR hybrid peptide targeting Hsp90 and Hsp70-targeted peptide.Hsp90 (heat shock protein 90) inhibitor occupancy is a direct determinant of client protein degradation and tumor growth arrest in vivo Radioimmunotherapy with α-particle-emitting radionuclides.17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2 Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant Chemoradiation Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer.Emerging drugs in the treatment of pancreatic cancer.Retaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent.Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.Molecular basis for the actions of Hsp90 inhibitors and cancer therapy.Radioimmunotherapy for peritoneal cancers.HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer.A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer.Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models.The expanding proteome of the molecular chaperone HSP90.Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent.Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases.Adapting to stress - chaperome networks in cancer.

P2860

Q24604068-6A170FE3-A290-489F-8362-D1F8F5D4EB9A Q27851619-C0322FC6-8AAF-4E28-801B-AFF2D5A33892 Q28247643-74EE2F25-6BAB-40BC-A3A8-5057C0FAF980 Q28542855-BD2ADCCE-956C-4411-89BF-5671978FFB52 Q30502529-F9A19985-BC79-4AE3-BAE5-C5AB4C471170 Q33710107-942C9992-28F4-4621-BBDE-4F9D5D11CAD5 Q33720758-815B72E2-88A1-423D-8F1D-127F0DB15958 Q33791981-0DDAB0A1-1395-4028-A24B-F8DD55241F87 Q33864394-34B349D0-9286-4FEB-9E57-2B4182B61546 Q33949308-B8C911CA-5F2C-4B16-A182-E07D33B59780 Q34129993-88BC86A4-AE7F-420F-8343-9467616C1477 Q34400894-2D2C7E44-D020-4377-8E17-D466816EA3A4 Q34419562-10DAC5D9-9CBD-4FC8-B1DC-8E49A12ED4D7 Q34989144-4317B764-9779-41CD-84E2-AD1514E37BBA Q35406116-FA85A4B1-7839-4980-BE89-C2292407CE5C Q35517613-48F1D8A8-C819-409F-BC7D-41BB58C476F6 Q35616720-8FAB5958-CE2B-43EE-8B2A-3CC18E30B3FA Q36402983-0A666F65-A6BE-41F8-A367-573D4A8F565D Q36490656-5F91277D-63A8-4D9C-89B8-DE2ABDEEC0F3 Q36821702-24D4DDE5-1664-46DE-81A0-04A8BD5903EA Q37494647-FA98B9CA-123A-452C-B4D8-3907D387CC27 Q37566640-1C9A905C-8433-454D-91C1-2AB64BAA3274 Q37772399-4109E40D-CED5-42B7-992B-5BCEFCFA0A9F Q37910724-6EA2B84D-4E7B-4E30-AEA6-5A816C2052F5 Q38096059-C4349FAD-9615-4F5C-BD21-0AAB728EC738 Q38729418-3D426E63-4087-4B5E-8713-C4C542721CB9 Q38740513-BCDBB8DD-D401-4456-8A28-2477D8E70A02 Q38903322-AD27B71C-4489-4C0E-9CAF-DD32CEF9951E Q38966874-07D36D5E-362D-4DC2-8C85-761EFB77D0C2 Q39640356-946CB41D-C303-44BF-91D5-8D88E56A8C7C Q41660505-27AE23DB-45A1-4DF4-A90D-88D33CDE9FC8 Q42588374-BFCC251B-A119-492B-AFB2-31AD8D572007 Q45877161-07BD4F3E-0106-496B-ABD1-95D8E4EF3ABF Q54425017-54F8172D-BBF1-4182-BA36-23116C0D8ACC

P2860

Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer.

http://www.wikidata.org/entity/Q39929797

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Antitumor activity and molecul ...... IPI-504, in pancreatic cancer.

@en

Antitumor activity and molecul ...... IPI-504, in pancreatic cancer.

@nl

type

label

Antitumor activity and molecul ...... IPI-504, in pancreatic cancer.

@en

Antitumor activity and molecul ...... IPI-504, in pancreatic cancer.

@nl

prefLabel

Antitumor activity and molecul ...... IPI-504, in pancreatic cancer.

@en

Antitumor activity and molecul ...... IPI-504, in pancreatic cancer.

@nl

P1433

Q39929797-0DB7E850-2452-4F80-A5E4-1C1A45531951

P1476

Q39929797-03008ADA-C6DB-41CD-A8DC-0A318B6257D0

P2093

Q39929797-25911EEF-9DD3-4C0D-A7D7-21512CB39F34

Q39929797-4FCA7AC2-48F5-4A2B-A0F3-71B91C366AE4

Q39929797-56189065-92E1-4910-A1B5-7E70BB82C5D0

Q39929797-631BFC7B-1E76-4696-8C51-0CB218A907DA

Q39929797-7B44912D-E2CC-4D89-9195-30B8E3710342

Q39929797-8C090C2D-6132-4FE0-89F3-564619994233

Q39929797-993ABDD6-0570-4496-9086-2135C486E0F2

Q39929797-A83639C0-9340-465B-A187-32770C1530D1

Q39929797-B60E0676-934C-46CC-A57B-70790159CEC6

Q39929797-C313F3BA-296F-41F4-98CC-390DAB207E7F

P304

Q39929797-D052BE6E-7A9C-4A11-945F-B0D2DD91E634

P31

Q39929797-208022A7-2E02-43B0-883C-5EBCFDBBA9C3

P356

Q39929797-80F09EFA-3106-45C9-9F8B-3491BEAFCA2B

P433

Q39929797-8456E537-5719-4151-A95E-F549D6B5CCCF

P478

Q39929797-97E6F4BD-6E22-4AA0-9C7B-E25E95692979

P50

Q39929797-2C94E51D-C5D4-4300-900E-5DDCCDA655A3

Q39929797-CFE2DFB2-5A80-41C0-B665-3B27DD3F37EF

P577

Q39929797-C7274EBE-B6CB-4123-B37F-FC3BC86F570C

P698

Q39929797-593D98AD-CD74-4023-B1A9-FE8E193EA426

P921

Q39929797-9FE9382A-7C79-4A3A-BEE1-3D5014C12621

P356

1535-7163.MCT-08-0508

P1433

Molecular Cancer Therapeutics

P1476

Antitumor activity and molecul ...... IPI-504, in pancreatic cancer

@en

P2093

Akhilesh Pandey

http://www.w3.org/2001/XMLSchema#string

Ana Suárez-Gauthier

http://www.w3.org/2001/XMLSchema#string

Anna Solomon

http://www.w3.org/2001/XMLSchema#string

Antonio Jimeno

http://www.w3.org/2001/XMLSchema#string

Anuradha Nalli

http://www.w3.org/2001/XMLSchema#string

Christian Fritz

http://www.w3.org/2001/XMLSchema#string

Dongweon Song

http://www.w3.org/2001/XMLSchema#string

Elena García-García

http://www.w3.org/2001/XMLSchema#string

Fernando López-Ríos

http://www.w3.org/2001/XMLSchema#string

Jeffrey Tong

http://www.w3.org/2001/XMLSchema#string

P304

3275-3284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-08-0508

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18852131

http://www.w3.org/2001/XMLSchema#string

P921

retaspimycin hydrochloride